NIH-funded research Fellowship grant

Understanding how mitochondrial issues lead to muscle loss as we age.

Official title: Mechanism of mitochondria-induced proteostatic signaling and progressive muscle atrophy during aging.

Funded at Upstate Medical University · NIH-10931389 · Data updated 2026-11-12

This study looks at how problems with tiny energy factories in our muscles, called mitochondria, can lead to muscle loss and weakness as we get older, using special mice to help understand these changes better.

More Aging research and trials

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUpstate Medical University
NIH-funded
Lab location1 site (Syracuse, United States)
Project startSeptember 14, 2023
Project endSeptember 13, 2027
Funding year2024
Award (this year)$53,974
NIH project number5F30AG082400-02
Project IDNIH-10931389 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults experiencing muscle weakness or atrophy, as well as individuals with conditions that affect muscle health.

Less likely to help

Patients who are not experiencing muscle atrophy or related conditions may not benefit from this research.

What this research studies

This research investigates the mechanisms behind muscle atrophy, particularly how mitochondrial dysfunction contributes to the loss of muscle mass and strength during aging. It focuses on the balance between protein synthesis and degradation in skeletal muscle, exploring how disturbances in this balance can lead to muscle wasting. The study employs a transgenic mouse model to examine the effects of mitochondrial damage on protein import and overall muscle health, aiming to uncover new insights into the biological processes involved.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating muscle loss in aging individuals.

How similar studies have gone: While mitochondrial dysfunction has been studied in relation to muscle atrophy, this specific approach using transgenic models to explore proteostatic signaling is relatively novel.

Where this research is happening

  • Upstate Medical University
    Syracuse, United States
    Active

Researchers

  • Principal investigator: Brennan, Nicholas — Upstate Medical University
  • Study coordinator: Brennan, Nicholas

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.